Published on
Dec 17, 2024
GLP-1 RAs May Cut Risk for Late-Onset Epilepsy
LOS ANGELES — Newer glucose-lowering drugs reduce the risk for late-onset seizures and epilepsy by 24%, with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) cutting the risk by 33%, according to a new meta-analysis. These results are “amazing” …
Source:
Medscape
-
Neutral
